Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Inogen Inc (INGN) USD0.001

Sell:$68.92 Buy:$69.00 Change: $2.20 (3.09%)
NASDAQ:1.55%
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$68.92
Buy:$69.00
Change: $2.20 (3.09%)
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$68.92
Buy:$69.00
Change: $2.20 (3.09%)
Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.

Contact details

Address:
326 Bollay Dr
GOLETA
93117-5550
United States
Telephone:
+1 (805) 5620500
Website:
https://www.inogen.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
INGN
ISIN:
US45780L1044
Market cap:
$1.56 billion
Shares in issue:
21.93 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Heath Lukatch
    Independent Chairman of the Board
  • Scott Wilkinson
    President, Chief Executive Officer, Director
  • Alison Bauerlein
    Executive Vice President - Finance and Chief Financial Officer, Corporate Secretary and Corporate Treasurer
  • Byron Myers
    Executive Vice President of Sales and Marketing
  • Bart Sanford
    Executive Vice President, Operations
  • Brenton Taylor
    Executive Vice President - Engineering

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.